← Open Payments lookup

KARI HURT: Open Payments

NPI 1669943320 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$895 in 52 payments from 16 companies in 2025. Trend: 2023 $287 · 2024 $505 · 2025 $895

Food & beverage: $895
CompanyPaymentsAmount
Intercept Pharmaceuticals, Inc.24$180
Madrigal Pharmaceuticals3$149
Gilead Sciences, Inc.5$127
Mirum Pharmaceuticals, Inc.3$73
Ipsen Biopharmaceuticals, Inc3$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$63
Azurity Pharmaceuticals, Inc.2$46
Ethicon US, LLC1$43
ANI Pharmaceuticals, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$20

Products named: OCALIVA, REZDIFFRA, Livmarli, IQIRVO, XIFAXAN, VISTASEAL, PURIFIED CORTROPHIN GEL, GATTEX.

Industry payments across GA — which companies pay providers there.